On Monday, PMC-Sierra Inc (NASDAQ:PMCS)’s shares declined -2.4% to $7.72.
PMC-Sierra Inc (PMCS) declared the appointment of Edward Sharp as chief strategy and technology officer. He reports to Greg Lang, PMC president and chief executive officer.
In this role, Sharp is responsible for leading PMC’s worldwide strategy and technology efforts, mapping emerging technologies into solutions that shape how the world consumes data. The exploding growth of big data puts PMC in a strong position to capitalize on the convergence of storage and networking, and to guide future industry-wide developments by participating in standards organizations.
Prior to joining PMC, Mr. Sharp was vice president of NetApp’s Emerging Products Group. He served in a number of roles of increasing scope in NetApp’s marketing, sales and product organizations from 1998 to 2014. Before joining NetApp, Mr. Sharp held positions at McKinsey & Company in the United States and the United Kingdom. He holds a Master of Science in Electrical Engineering from Stanford University and a Bachelor of Arts in Engineering, Economics and Administration from Oxford University.
PMC-Sierra, Inc. designs, develops, markets, and supports semiconductor solutions for communications network infrastructure equipment worldwide. Its semiconductor devices enable networking equipment primarily in three markets, counting storage, optical, and mobile networks.
American Apparel Inc (NYSEMKT:APP)’s shares dropped -1.73% to $0.295.
American Apparel, Inc. (APP), a vertically-integrated manufacturer, distributor, and retailer of branded fashion-basic apparel, recently declared another leadership appointment. Brian McHale has been named Senior Vice President and Chief Information Officer.
As Chief Information Officer, McHale will oversee information technology and computer systems at the company. In addition to providing critical support to American Apparel’s onsite hardware and software applications, McHale will also lead the development and expansion of the company’s retail digital capabilities alongside Thoryn Stephens, recently designated Chief Digital Officer.
McHale comes to American Apparel with over 25 years of experience developing IT governance, Business Intelligence and Big Data solutions for some of the U.S.’s largest companies such as DirecTV and Verizon. He has also transformed these companies to cloud-based infrastructures, driving efficiencies and cost savings. McHale’s experience comprises work for agency clients in a variety of categories, counting turnaround businesses, similar to American Apparel.
American Apparel, Inc. designs, manufactures, distributes, retails, and sells branded fashion basic apparel products, and clothing and accessories for women, men, children, and babies. It offers T-shirts, denim, sweaters, jackets, and accessories. The company sells its products through the wholesale distribution channel, counting supplying T-shirts and other casual wear to distributors and screen printers; direct to customers through its retail stores; and through an online retail e-commerce Website, americanapparel.com.
At the end of Monday’s trade, Terex Corporation(NYSE:TEX)‘s shares dipped -1.27% to $22.58.
Terex Corporation (TEX) will host a one-hour conference call to review its second quarter 2015 financial results on Thursday, July 30, 2015 at 8:00 a.m. EDT. Ronald M. DeFeo, Chairman and CEO, will host the call. The Company will release its financial results preceding to the call.
Terex Corporation operates as a lifting and material handling solutions company. Its Aerial Work Platforms segment designs, manufactures, services, and markets aerial work platform equipment, telehandlers, and light towers, in addition to related components and replacement parts under Terex and Genie names.
TrovaGene Inc (NASDAQ:TROV), ended its Monday’s trading session with 3.59% gain, and closed at $9.52.
Trovagene, Inc. (TROV), a developer of cell-free molecular diagnostics, recently declared the pricing of an underwritten public offering of 4,000,000 shares of its common stock. The gross proceeds to Trovagene from this offering are predictable to be $35 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Trovagene. The offering is predictable to close on or about July 22, 2015, subject to customary closing conditions. Trovagene has also granted to the underwriters a 30-day option to purchase from it up to an additional 600,000 shares of its common stock.
Trovagene intends to use the net proceeds from this offering to fund its research and development activities and for working capital and other general corporate purposes.
Piper Jaffray & Co. and Leerink Partners LLC are acting as joint book-running managers for the offering. Janney Montgomery Scott LLC, Cantor Fitzgerald & Co. and Maxim Group LLC are acting as co-managers for the offering.
Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. The company intends to enhance the treatment outcomes for cancer patients through its proprietary technology to detect and quantitatively monitor cell-free DNA using urine or blood samples. It is developing PCM BRAF and KRAS mutation detection tests for detecting mutations in metastatic cancer patients; and HPV HR detection test to detect the presence of various HPV genotypes using a urine sample.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.